Showing results (201-210 of 372) with videos related to
Sort By:
Pageof 38
Multiple Sclerosis and Related Disorders|October 15, 2023
Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trialNicole Krause, Carlotta Derad, Barbara von Glasenapp, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2018
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.Trials|August 20, 2025
Randomized adaptive assessment of post COVID syndrome treatments (RAPID): a study protocol for a multicenter, randomized, controlled adaptive platform trial of treatment options for Post Covid Syndrome (PCS) on patients physical function including the first intervention specific appendix RAPID_REVIVE (reducing inflammatory activity in patients with PCS)Lisa Weipert, Ralph G Telgmann, Gabriele Anton, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|September 4, 2024
Adherence-enhancing interventions for pharmacological and oxygen therapy in patients with COPD: a systematic review and component network meta-analysesOmar Ammous, Regina Kampo, Maximilian Wollsching-Strobel, et al.European Journal of Heart Failure|April 23, 2024
Randomized investigation of the MitraClip device in heart failure: Design and rationale of the RESHAPE-HF2 trial designStefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2026
Cost-effectiveness of a GLS-based screening and prevention program for pre-heart failure compared to standard of careHannah Kentenich, Sebastian Kelle, Rebecca E Beyer, et al.Plos One|October 18, 2018
Insights into permanent pacemaker implantation following TAVR in a real-world cohortTobias Tichelbäcker, Leonard Bergau, Miriam Puls, et al.Trials|February 15, 2021
Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trialAnne Christin Rahn, Lisa Wenzel, Andrea Icks, et al.BMC Public Health|June 23, 2011
Warwick-Edinburgh Mental Well-being Scale (WEMWBS): validated for teenage school students in England and Scotland. A mixed methods assessmentAileen Clarke, Tim Friede, Rebecca Putz, et al.ESC Heart Failure|February 15, 2021
Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysisJaved Butler, Muhammad Shariq Usman, Muhammad Shahzeb Khan, et al.Pageof 38